24. Biomarker Development in ASD: Electrophysiological Response During Auditory Gap Detection is Associated With Symptom Severity and May Index Excitatory/Inhibitory Imbalance

      Several rare genetic disorders that result in an ASD phenotype (e.g., Fragile X syndrome, Phelan-McDermid syndrome) implicate alterations in excitatory/inhibitory neurotransmitter balance. Recently, the search for sensitive and reliable biomarkers indexing specific neural processes and relevant for measuring treatment response has intensified in ASD research. Auditory gap detection is a low-level sensory function that: a) is impaired in ASD and other communication disorders, b) is sensitive to perturbations in E/I balance, and c) can be indexed with electrophysiology (EEG). This study tested whether electrophysiological response during gap detection is impaired in ASD, associated with clinical variables, and a potentially viable biomarker for ASD.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect